Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an announcement.
Resmed Inc announced a net decrease in the number of CHESS Depositary Interests (CDIs) issued over quoted securities for August 2025, with a reduction of 4,204,410 CDIs compared to the previous month. This change is attributed to net transfers between CDIs and common stock on the NYSE, as well as activities related to stock options, restricted stock units, employee stock purchase plans, and share repurchases. The announcement reflects the company’s ongoing management of its securities and may impact its market positioning and stakeholder interests.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$47.25 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Resmed Inc operates in the healthcare industry, focusing on the development and manufacturing of products for the treatment of sleep disorders, respiratory care, and related medical conditions. The company is known for its innovative solutions in sleep apnea therapy and ventilation support, catering to a global market.
Average Trading Volume: 921,318
Technical Sentiment Signal: Buy
Current Market Cap: A$61.6B
For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.